Cardiovascular proteomics is a specialized field within the broader domain of proteomics, dedicated to the in-depth investigation of proteins related to cardiovascular health and disease. This scientific discipline employs advanced techniques to comprehensively analyze the intricate protein landscape of the cardiovascular system. By delving into the complexities of protein expression, post-translational modifications, and interactions, researchers in cardiovascular proteomics strive to uncover vital insights into the molecular mechanisms underlying various cardiovascular conditions. This nuanced approach not only enhances our understanding of heart-related diseases but also opens new avenues for identifying potential biomarkers, unraveling disease progression pathways, and pinpointing therapeutic targets. The integration of cutting-edge technologies, such as high-throughput mass spectrometry, empowers scientists to systematically explore the intricate interplay of proteins, contributing to the ongoing pursuit of innovative diagnostic methods and targeted therapeutic interventions in the dynamic field of cardiovascular health.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation